Back
Direxion Daily S&P Biotech Bull 3X Shares Vs. Nebius Group NV Industry Stock Comparison
Buy
61
LABU
Direxion Daily S&P Biotech Bull 3X Shares
Last Price:
$164.95
Seasonality Move:
-11.35%
Sell
42
NBIS
Nebius Group NV
Last Price:
$89.47
Seasonality Move:
-2.57%
Buy
61
Direxion Daily S&P Biotech Bull 3X Shares (LABU)
is a Buy
Is Direxion Daily S&P Biotech Bull 3X Shares a Buy, Sell or Hold?
-
The current Direxion Daily S&P Biotech Bull 3X Shares [LABU] share price is $165.53. The Score for LABU is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
LABU is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nebius Group NV (NBIS)
is a Sell
Is Nebius Group NV a Buy, Sell or Hold?
-
The current Nebius Group NV [NBIS] share price is $89.46. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LABU Stock Price Chart
What is Direxion Daily S&P Biotech Bull 3X Shares's stock price today?
-
The Direxion Daily S&P Biotech Bull 3X Shares share price today is $165.53Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LABU is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBIS Stock Price Chart
What is Nebius Group NV's stock price today?
-
The Nebius Group NV share price today is $89.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.
LABU Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.08 | Buy |
| Relative Strength Index (14 RSI): | 60.53 | Buy |
| Chaikin Money Flow: | 464591 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (143.18 - 166.44) | Buy |
| Bollinger Bands (100): | (73.22 - 142.04) | Buy |
NBIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.05 | Sell |
| Relative Strength Index (14 RSI): | 47.32 | Sell |
| Chaikin Money Flow: | 13904832 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (83.34 - 98.02) | Sell |
| Bollinger Bands (100): | (72.32 - 115.66) | Sell |
LABU Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 161.06 | Buy |
| 20-day SMA: | 159.76 | Buy |
| 50-day SMA: | 137.56 | Buy |
| 200-day SMA: | 83.37 | Buy |
| 8-day EMA: | 160.34 | Buy |
| 20-day EMA: | 155.92 | Buy |
| 50-day EMA: | 137.5 | Buy |
| 200-day EMA: | 74.37 | Buy |
NBIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.08 | Buy |
| 20-day SMA: | 91.37 | Sell |
| 50-day SMA: | 102.98 | Sell |
| 200-day SMA: | 65.21 | Buy |
| 8-day EMA: | 85.42 | Buy |
| 20-day EMA: | 90.53 | Sell |
| 50-day EMA: | 95.55 | Sell |
| 200-day EMA: | 73.6 | Buy |
Direxion Daily S&P Biotech Bull 3X Shares Earnings Growth & LABU Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Nebius Group NV Earnings Growth & NBIS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.
Direxion Daily S&P Biotech Bull 3X Shares Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nebius Group NV Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||